Colleen Corey - 26 Apr 2023 Form 3 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Global Human Resources
Signature: /s/ Colleen Corey
Issuer symbol: BIO
Transactions as of: 26 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 04 May 2023, 17:06:49 UTC
Next filing: 06 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BIO	Bio-Rad A Common Stock						15,880	26 Apr 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BIO	Restricted Stock Units							26 Apr 2023	Bio-Rad A Common Stock	600	$0.000000	Direct	F1, F6
holding	BIO	Restricted Stock Units							26 Apr 2023	Bio-Rad A Common Stock	990	$0.000000	Direct	F2, F6
holding	BIO	Restricted Stock Units							26 Apr 2023	Bio-Rad A Common Stock	722	$0.000000	Direct	F3, F6
holding	BIO	Restricted Stock Units							26 Apr 2023	Bio-Rad A Common Stock	760	$0.000000	Direct	F4, F6
holding	BIO	Restricted Stock Units							26 Apr 2023	Bio-Rad A Common Stock	1,388	$0.000000	Direct	F5, F6
holding	BIO	Non-Qualified Stock Option (right to buy)							26 Apr 2023	Bio-Rad A Common Stock	1,444	$524.30	Direct	F7
holding	BIO	Non-Qualified Stock Option (right to buy)							26 Apr 2023	Bio-Rad A Common Stock	1,013	$814.95	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F2	On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F3	On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4	On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5	On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F7	The option, representing a right to purchase a total of 1,444 shares, becomes exercisable in four equal annual installments beginning on September 2, 2021, which is the first anniversary of the date on which the option was granted.
F8	The option, representing a right to purchase a total of 1,013 shares, becomes exercisable in four equal annual installments beginning on September 1, 2022, which is the first anniversary of the date on which the option was granted.